The integrated role of ultrasonography in the diagnosis of soft tissue metastases from melanoma: Preliminary report of a single-center experience and literature review

In Vivo

Volumn 27, Issue 6, 2013, Pages 827-834

  Covarelli, Piero ^a   Burini, Gloria ^a   Barberini, Francesco ^a   Caracappa, Daniela ^a   Boselli, Carlo ^a   Noya, Giuseppe ^a   Castellani, Elisa ^a   Rulli, Antonio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Melanoma; Nodal metastases; Surgery; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISTANT METASTASIS; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MALE; MELANOMA; NON INVASIVE PROCEDURE; POSITRON EMISSION TOMOGRAPHY; RELIABILITY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SOFT TISSUE METASTASIS;

MELANOMA; NODAL METASTASES; SURGERY; ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS;

EID: 84892716573     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. MacKie RM, Hauschild A and Eggermont AM: Epidemiology of invasive cutaneous melanoma. Ann Oncol 20(Suppl 6): vi1-vi7.2, 2009.
2. Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, Dimaio D, Guild V, Halpern AC, Hodi FS, Kashani-Sabet M, Lange JR, Lind A, Martin L, Martini MC, Pruitt SK, Ross MI, Sener SF, Swetter SM, Tanabe KK, Thompson JA, Trisal V, Urist MM, Weber J and Wong MK: NCCN Melanoma Panel. J Natl Compr Canc Netw 7(3): 250-275, 2009.
3. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG and Edwards BK (eds.). SEER Cancer Statistics Review, 1975-2006. 2009. Available at http://seer.cancer.gov/csr/1975-2006/.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59(4): 225-249, 2009.
5. Ferlay J, Bray F, Pisani P and Parkin DM: GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5, version 2.0. IARC Press, Lyon, 2004.
6. AIRTUM Epidemiology and prevention, year 34 sept.dec. 2010 supplement 4. Article in Italian.
7. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ and Cochran AJ: Technical details of intraoperative lymphatic mapping for early-stage melanoma. Arch Surg 127(4): 392-399, 1992.
8. Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, Royal R and Cormier JN: Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: A meta-analysis. J Natl Cancer Inst 103(2): 129-142, 2011.
9. Jouvet JC, Thomas L, Thomson V, Yanes M, Journe C, Morelec I, Bracoud L, Durupt F, Giammarile F and Berthezene Y: Wholebody MRI with diffusion-weighted sequences compared with 18FFDG PET-CT, CT and superficial lymph node US in the staging of advanced cutaneous melanoma: A prospective study. J Eur Acad Dermatol Venereol, 2013.
10. Sanki A, Uren RF, Moncrieff M, Tran KL, Scolyer RA, Lin HY and Thompson JF: Targeted high-resolution US is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol 27(33): 5614-5619, 2009.
11. Voit CA, van Akkooi AC, Schafer-Hesterberg G, Schoengen A, Schmitz PI, Sterry W and Eggermont AM: Rotterdam criteria for sentinel node (SN) tumor burden and the accuracy of US (US)-guided fine-needle aspiration cytology (FNAC): Can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol 27(30): 4994-5000, 2009.
12. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, Lee JJ, Balch CM, Reintgen DS and Ross MI: Multinstitutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17: 976-983, 1999.
13. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ and Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127: 392-399, 1992.
14. McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A, Fenske N, Glass F, Balch CM and Coit DG: Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 19: 2851-2855, 2001.
15. AJCC (American Joint Committee on Cancer) Cancer Staging Handbook: TNM Classification of Malignant Tumors. 6th ed. New York: Springer-Verlag, 2002.
16. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH and Morabito A: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19 (16): 3622-3634, 2001.
17. Unger JM, Flaherty LE, Liu PY, Albain KS and Sondak VK: Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer 91(6): 1148-1155, 2001.
18. Lens MB, Dawes M, Newton-Bishop JA and Goodacre T: Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg 89(10): 1223-1227, 2002.
19. Covarelli P, Vedovati MC, Becattini C, Rondelli F, Tomassini GM, Messina S, Noya G, Bistoni G and Simonetti S: The sentinel node biopsy in patients with thick melanoma: Outcome analysis from a single-institution database. In Vivo 25(3): 439-443, 2011.
20. Rondelli F, Vedovati MC, Becattini C, Tomassini GM, Messina S, Noya G, Simonetti S and Covarelli P: Prognostic role of sentinel node biopsy in patients with thick melanoma: a metaanalysis. J Eur Acad Dermatol Venereol 26(5): 560-565, 2012.
21. Baughan CA, Hall VL, Leppard BJ and Perkins PJ. Follow-up in stage I cutaneous malignant melanoma: an audit. Clin Oncol. 5(3): 174-180, 1993.
22. Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P and O'Fallon JR. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA 274 (21): 1703-1705, 1995.
23. Mooney MM, Kulas M, McKinley B, Michalek AM and Kraybill WG: Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma. Ann Surg Oncol 5 (1): 54-63, 1998.
24. Belhocine T, Pierard G, De Labrassinne M, Lahaye T and Rigo P: Staging of regional nodes in AJCC stage I and II melanoma: 18FFDG PET imaging versus sentinel node detection. Oncologist 7(4): 271-278, 2002.
25. Wagner JD, Schauwecker D, Davidson D, Logan T, Coleman JJ 3rd, Hutchins G, Love C, Wenck S and Daggy J: Inefficacy of 18F fluorodeoxy-D-glucose positron-emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer 104 (3): 570-579, 2005.
26. Acland KM, O'Doherty MJ and Russell-Jones R: The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma. J Am Acad Dermatol 42: 606-611, 2000.
27. Wagner JD, Schauwecker DS, Davidson D, Wenck S, Jung SH and Hutchins G: 18FFDG PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol 77: 237-234, 2001.
28. Kokoska MS, Olson G, Kelemen PR, Fosko S, Dunphy F, Lowe VJ and Stack BC Jr.: The use of lymphoscintigraphy and PET in the management of head and neck melanoma. Otolaryngol Head Neck Surg 125: 213-220, 2001.
29. Wagner JD, Schauwecker D, Davidson D, Coleman JJ 3rd, Saxman S, Hutchins G, Love C and Hayes JT: Prospective study of 18Ffluorodeoxyglucose positron-emission tomography imaging of lymph node basins in melanoma patients undergoing sentinel node biopsy. J Clin Oncol 17: 1508-1515, 1999.
30. Acland KM, Healy C, Calonje E, O'Doherty M, Nunan T, Page C, Higgins E and Russell-Jones R: Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol 19: 2674-2678, 2001.
31. Singh B, Ezziddin S, Palmedo H, Reinhardt M, Strunk H, Tüting T, Biersack HJ and Ahmadzadehfar H: Preoperative 18FFDG PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Melanoma Res 18(5): 346-352, 2008.
32. Niebling MG, Bastiaannet E, Hoekstra OS, Bonenkamp JJ, Koelemij R and Hoekstra HJ: Outcome of Clinical Stage III Melanoma Patients with 18FFDG PET and Whole-Body CT Added to the Diagnostic Workup. Ann Surg Oncol, 2013.
33. Bastiaannet E, Uyl-de Groot CA, Brouwers AH, van der Jagt EJ, Hoekstra OS, Oyen W, Verzijlbergen F, van Ooijen B, Thompson JF and Hoekstra HJ: Cost-effectiveness of adding 18FFDG PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann Surg 255 (4): 771-776, 2012.
34. Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S and Hoekstra HJ: Prospective comparison of 18Ffluorodeoxyglucose positron-emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: Diagnostic accuracy and impact on treatment. J Clin Oncol 27(28): 4774-4780, 2009.
35. Blum A, Schlagenhauff B, Stroebel W, Breuninger H, Rassner G and Garbe C: Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma: Results of a prospective study of 1288 patients. Cancer 88(11): 2534-2539, 2000.
36. Brountzos EN, Panagiotou IE, Bafaloukos DI and Kelekis DA: Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma. Oncol Rep 10(2): 505-510, 2003.
37. Schmid-Wendtner MH, Paerschke G, Baumert J, Plewig G and Volkenandt M: Value of US compared with physical examination for the detection of locoregional metastases in patients with cutaneous melanoma. Melanoma Res 13(2): 183-188, 2003.
38. Sijan G, Kozarski J, Stefanoviæ D, Lalkoviæ M, Miliæeviæ S and Stankoviæ G: Ultrasonographic findings validity in the identification of metastatic regional lymph nodes in patients with cutaneous melanoma. Vojnosanit Pregl 67(1): 25-31, 2010. Article in Serbian.
39. Voit C, Mayer T, Kron M, Schoengen A, Sterry W, Weber L and Proebstle TM: Efficacy of US B-scan compared with physical examination in follow-up of melanoma patients. Cancer 91(12): 2409-2416, 2001.
40. Hocevar M, Bracko M, Pogacnik A, Vidergar-Kralj B, Besic N, Zgajnar J and Music MM: The role of preoperative US in reducing the number of sentinel lymph node procedures in melanoma. Melanoma Res 14(6): 533-536, 2004.
41. Rossi CR, Mocellin S, Scagnet B, Foletto M, Vecchiato A, Pilati P, Tregnaghi A, Zavagno G, Stramare R, Rubaltelli L, Montesco C, Borsato S, Rubello D and Lise M: The role of preoperative US scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol 83(2): 80-84, 2003.
42. Tyler DS, Onaitis M, Kherani A, Hata A, Nicholson E, Keogan M, Fisher S, Coleman E and Seigler HF: Positron-emission tomography scanning in malignant melanoma. Cancer 89(5): 1019-1025, 2000.
43. Sabel MS and Wong SL: Review of evidence-based support for pretreatment imaging in melanoma. J Natl Compr Canc Netw 7(3): 281-289, 2009.
44. Xing Y, Bronstein Y, Ross MI, Askew RL, Lee JE, Gershenwald JE, Royal R and Cormier JN: Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: A meta-analyses. J Natl Cancer Inst 103(2): 129-142, 2011.